The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity
- 1 December 1998
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 37 (12) , 1445-1458
- https://doi.org/10.1016/s0028-3908(98)00145-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responsesPublished by Elsevier ,2000
- LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsNeuropharmacology, 1998
- (R,S)-α-methyl-4-carboxyphenylglycine (MCPG) fails to block long-term potentiation under urethane anaesthesia in vivoNeuropharmacology, 1997
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- Long-Term Depression in HippocampusAnnual Review of Neuroscience, 1996
- Activation of group I mG1uRs potentiates NMDA responses in rat hippocampal slicesNeuroscience Letters, 1996
- Activation of metabotropic glutamate receptors is necessary for long-term potentiation in the dentate gyrus and for spatial learningNeuropharmacology, 1994
- Postsynaptic Induction and Presynaptic Expression of Hippocampal Long-Term DepressionScience, 1994
- A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiationNature, 1994
- Competitive antagonism at metabotropic glutamate receptors by (S) -4-carboxyphenylglycine and (RS) -α-methyl-4-carboxyphenylglycineEuropean Journal of Pharmacology: Molecular Pharmacology, 1993